MedTrace Logo

Efficacy of BLIS K12 as Preventive Measure for Rheumatic Children

NCT02407106 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-04-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether daily treatment with Streptococcus Salivarius BLIS K-12 prevents streptococcal throat infection in children that have had an episode of rheumatic fever.

Conditions

  • Rheumatic Fever

Interventions

DIETARY_SUPPLEMENT

Streptococcus Salivarius BLIS K12

Once daily tablet of BLIS K 12 to be slowly dissolved orally every evening.

Sponsors & Collaborators

  • Kaplan Medical Center

    lead OTHER

Principal Investigators

  • Yael Garty, MD · Attending physician

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02407106 on ClinicalTrials.gov